Login / Signup

Is QTc the Right Surrogate in Adequately Assessing the Risk for TdP for Development Compound Candidates? A Call to Investigate.

Rajesh Krishna
Published in: Journal of clinical pharmacology (2021)
Keyphrases
  • amyotrophic lateral sclerosis
  • breast cancer risk